Rexahn Pharmaceuticals Inc (RNN.A)

RNN.A on American Stock Exchange

0.31USD
3:59pm EDT
Price Change (% chg)

$-0.03 (-7.94%)
Prev Close
$0.34
Open
$0.33
Day's High
$0.33
Day's Low
$0.31
Volume
32,200
Avg. Vol
141,745
52-wk High
$1.28
52-wk Low
$0.31

RNN.A

Chart for RNN.A

About

Rexahn Pharmaceuticals, Inc. (Rexahn) is a clinical stage biopharmaceutical company developing and seeking to deliver cures for cancer and disorders of the central nervous system (CNS) to patients worldwide. Rexahn’s pipeline features three drug candidates in Phase II clinical trials and seven or more other drug candidates in... (more)

Overall

Beta: 1.44
Market Cap (Mil.): $31.46
Shares Outstanding (Mil.): 95.35
Dividend: --
Yield (%): --

Financials

  RNN.A Industry Sector
P/E (TTM): -- 49.13 43.38
EPS (TTM): -0.09 -- --
ROI: -51.78 10.38 9.53
ROE: -70.17 11.64 11.11
Search Stocks

Competitors

  Price Change
Bristol Myers Squibb Co. (BMY.N) $35.09 +0.57
Bristol Myers Squibb Co. (BMY_p.N) $568.10 0.00
Eli Lilly & Co. (LLY.N) $41.93 +0.36
Novartis AG (NOVN.VX) CHF52.80 +0.55
GlaxoSmithKline plc (GSK.L) 1,470.00p -3.50
Keryx Biopharmaceuticals (KERX.OQ) $1.79 +0.06
Genta Incorporated (GNTA.PK) $0.00 -0.00
Pfizer Inc. (PFE.N) $22.61 +0.19

  Earnings  vs    Estimates

Analyst Research Reports

Report Title Price
Thomson Reuters Stock Report - REXAHN PHARMACEUTICALS INC. (RNN-A)
Provider: Thomson Reuters Stock Report
$25.00
Buy
REXAHN PHARMACEUTICALS INC (RNN) 2-weeks forecast
Provider: Pechala's Reports
$10.00
Buy
Rexahn Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Rexahn Pharmaceuticals, Inc. (RNN) - Financial Analysis Review
Provider: GlobalData
$242.00
Buy
REXAHN PHARMACEUTICALS INC (RNN) 12-months forecast
Provider: Pechala's Reports
$15.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research
Search Stocks